SEARCH
Sun Pharma allays corp governance issues, experts discuss
CNBC-TV18
2019-01-22
Views
0
Description
Share / Embed
Download This Video
Report
Maybe some of the current issues raised have been addressed by Sun Pharma to some extent, said hriram Subramanian of Ingovern but investors who pay premium for corporate governance would stay away from the stock for a while.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://www.dailytv.net//embed/x712oac" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
02:07
Palace closely monitoring CoVID-19, other health issues; Palace allays fear on Bubonic plague
32:23
Corp governance issues being raised among many companies is a genuine worry, says NR Narayana Murthy
22:27
Healthcare & pharma: Experts discuss how it performed in last 5 years
24:51
Video: Big Deal: Experts discuss second debt market issues
22:32
Experts discuss Delhi elections and the issues that matters to Delhi citizens
56:17
Govt issues travel advisory, terror threat still looms over Delhi? Experts discuss
01:05:55
World Water Summit: Experts discuss key issues, possible solutions to water crisis in India
02:19
Experts at Pyeongchang Global Peace Forum discuss global peace-related issues
25:38
Experts discuss key battles and top issues in phase 3 of 2019 Lok Sabha elections
02:02
Experts at Pyeongchang Global Peace Forum discuss global peace-related issues
02:29
Experts at Pyeongchang Global Peace Forum to discuss global peace-related issues
13:03
Experts discuss the need to bring the Lok Sabha election back to basic issues
